Xilio Therapeutics
24 hedge funds and large institutions have $22M invested in Xilio Therapeutics in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
35% less funds holding
Funds holding: 37 → 24 (-13)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Holders
24
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.13M | |
| 2 | +$918K | |
| 3 | +$452K | |
| 4 |
Renaissance Technologies
New York
|
+$204K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$112K |
Top Sellers
| 1 | -$2.56M | |
| 2 | -$1.3M | |
| 3 | -$757K | |
| 4 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$538K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$279K |
